Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA537405
Max Phase: Preclinical
Molecular Formula: C13H26Cl2N4
Molecular Weight: 236.36
Molecule Type: Small molecule
Associated Items:
ID: ALA537405
Max Phase: Preclinical
Molecular Formula: C13H26Cl2N4
Molecular Weight: 236.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)Nc1cncc(N(C)C(C)C)c1CN.Cl.Cl
Standard InChI: InChI=1S/C13H24N4.2ClH/c1-9(2)16-12-7-15-8-13(11(12)6-14)17(5)10(3)4;;/h7-10,16H,6,14H2,1-5H3;2*1H
Standard InChI Key: GVOMUCQQJILKJG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 236.36 | Molecular Weight (Monoisotopic): 236.2001 | AlogP: 2.21 | #Rotatable Bonds: 5 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.21 | CX LogP: 1.01 | CX LogD: 0.14 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.82 | Np Likeness Score: -0.83 |
1. Bertini V, Buffoni F, Ignesti G, Picci N, Trombino S, Iemma F, Alfei S, Pocci M, Lucchesini F, De Munno A.. (2005) Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases., 48 (3): [PMID:15689151] [10.1021/jm0408316] |
Source(1):